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We investigated the effect of different set-up error corrections on dose–volume metrics in intensity-modulated
radiotherapy (IMRT) for prostate cancer under different planning target volume (PTV) margin settings using
cone-beam computed tomography (CBCT) images. A total of 30 consecutive patients who underwent IMRT
for prostate cancer were retrospectively analysed, and 7–14 CBCT datasets were acquired per patient.
Interfractional variations in dose–volume metrics were evaluated under six different set-up error corrections,
including tattoo, bony anatomy, and four different target matching groups. Set-up errors were incorporated
into planning the isocenter position, and dose distributions were recalculated on CBCT images. These pro-
cesses were repeated under two different PTV margin settings. In the on-line bony anatomy matching groups,
systematic error (∑) was 0.3 mm, 1.4 mm, and 0.3 mm in the left–right, anterior–posterior (AP), and superior–
inferior directions, respectively. ∑ in three successive off-line target matchings was finally comparable with
that in the on-line bony anatomy matching in the AP direction. Although doses to the rectum and bladder wall
were reduced for a small PTV margin, averaged reductions in the volume receiving 100% of the prescription
dose from planning were within 2.5% under all PTV margin settings for all correction groups, with the excep-
tion of the tattoo set-up error correction only (≥5.0%). Analysis of variance showed no significant difference
between on-line bony anatomy matching and target matching. While variations between the planned and
delivered doses were smallest when target matching was applied, the use of bony anatomy matching still
ensured the planned doses.
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INTRODUCTION
Intensity-modulated radiotherapy (IMRT) techniques allow
the safe delivery of high-dose radiation to the prostate while
sparing adjacent normal structures, including the rectum and
bladder [1]. This requires accurate daily targeting throughout
the entire course of IMRT. A number of researchers have
investigated the localization and quantification of prostate
displacement using implanted fiducial markers and several
modalities, including kV X-ray planar images and cone-
beam computed tomography (CBCT) [2–7]. Hammond et al.
noted that residual set-up errors in the prostate with respect
to the planned position remain, even after bone alignment
[7]. In addition, several papers have described appropriate
set-up error corrections for reducing residual set-up error
using repeated CT scans [8, 9]. Hoogeman et al. and Snir
et al. reported that residual set-up error in the prostate could
be reduced using the data of four to five repeated CT scans
with off-line corrections [8, 9]. Meanwhile, some researchers
have analysed dose–volume metrics of the prostate, rectum
and bladder after bone matching or target matching (using
CT or CBCT images to assess the accuracy of the initial
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treatment plan) [5, 10]. To date, however, few studies have
comprehensively investigated dose–volume metrics under
the presence of residual set-up errors and different planning
target volume (PTV) margin settings.
Here, we investigated the effect of different set-up error
corrections on dose–volumemetrics in IMRT for prostate can-
cer under different PTV margin settings using CBCT images.
MATERIALS ANDMETHODS
Patients
The study enrolled 30 consecutive patients who underwent
IMRT for localized prostate cancer at our institution between
April 2011 and November 2011 (Table 1). Written informed
consent for IMRT was obtained from each patient before
treatment planning. Patients were provided with written and
verbal instructions regarding bowel and bladder preparation
before simulation and treatment. They took one capsule of
magnesium oxide (330 mg) orally three times per day to en-
courage defecation, and were instructed to empty their bowel
and bladder, and then drink 300–500 ml water 1 h before the
CT simulation and before each treatment.
Planning CT data acquisition and IMRT planning
At the CT simulation, patients were positioned supine on the
couch with the Hip-fix system, which includes the Pelvic-
Board, Spread Leg Vac-lok cushion (CIVCO Medical
Solutions, Kalona, IA), thermoplastic seat, and Foot-lok
cushion (Med-Tech, Orange City, IA, USA) (Fig. 1). The
Hip-fix system was developed in order to facilitate maintain-
ing natural width of leg opening and leg rotations [11].
Planning CT images were then acquired using a 4-slice CT
simulator (Light speed plus; General Electric Medical
Systems, Waukesha, WI) with a 2.5-mm slice thickness
without a gap from the iliac crest to 80 mm below the ischial
tuberosities. When large amounts of bowel gas and stool in
the rectal vault were observed, the patients were asked to
empty their bowels and bladder by radiological technicians.
After a second bowel and bladder preparation, a planning CT
scan was done on the same day. A single experienced radi-
ation oncologist removed bowel gas with a tube when large
amounts of bowel gas were still present.
After transfer of the CT images to a treatment-planning
system [Eclipse Helios, ver. 8.6.15 (Varian Medical Systems,
Palo Alto, CA)], the prostate, seminal vesicles (SVs), outer
rectal wall, outer bladder wall, small bowel, and large bowel
were manually contoured by the same medical physicist to
eliminate interobserver variation. The rectal wall was auto-
matically generated from the outer rectal wall using a wall-
extraction function with a wall thickness of 4 mm from
10 mm below the apex of the prostate to 10 mm above the
tips of the SVs. The bladder wall was also generated from
the outer bladder wall in the same manner as the rectal wall,
with a wall thickness of 4 mm. Clinical target volume (CTV)
was determined as follows: (i) the union of prostate with the
proximal one-third of the SVs for nine patients with a low-
or intermediate-risk prostate cancer in Stage B, (ii) the union
of prostate with the proximal two-thirds of the SVs for 20
patients with high-risk prostate cancer in Stage B, and (iii)
the union of the prostate with the SVs for one patient with
Stage T3b prostate cancer. In addition, the following two
PTV margin settings were employed in the present study: (i)
8-mm margins isotropically, except for a 5-mm margin pos-
teriorly (in the direction towards the rectum) and superiorly
(in the caudal direction) (PTV8/5 groups), and (ii) 5-mm
margins isotropically (PTV5/5 groups). Finally, all contours
were reviewed by the radiation oncologist.
An IMRT plan was designed for each of the above PTV
settings using Eclipse. The prescription doses were 70 Gy
for eight patients, 74 Gy for 12 patients, and 78 Gy for 10
patients, at 2 Gy per fraction. Seven coplanar ports with
gantry angles of 50°, 95°, 150°, 180°, 210°, 265° and 310°
Table 1. Patient characteristics
Age (years)






Prostate + 1/3 SV 9
Prostate + 2/3 SV 20
Prostate + SV 1
CTV = clinical target volume, SV = seminal vesicles.
Fig. 1. The Hip-fix system, which includes the Pelvic-Board,
Spread Leg Vac-lok cushion, thermoplastic seat, and Foot-lok
cushion.
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were selected for dose calculation. Beam energy and dose
rate were a 10-MV photon beam and 300 MU/min, respect-
ively. The well-commissioned Analytical Anisotropic Algorithm
(ver. 8.6.15) with heterogeneity correction was used for dose
calculation. Details regarding the dose–volume constraints
were as follows (Table 2).
PTV
(i) The maximum dose should be <110%; (ii) the volume
receiving 90% of the prescription dose should generally
be≥ 96% (≥98% is preferable); (iii) the dose received by 95%
volume should generally be ≥90% (≥95% is preferable); and
(iv) the mean dose should generally be 99–103% of the pre-
scription dose.
Rectum wall
(i) No more than 60% of the rectum wall volume should
receive >40 Gy; (ii) no more than 30% of the rectum wall
volume should receive >60 Gy, (3) no more than 20% of the
rectum wall volume should receive >70 Gy, and (4) no more
than 1% of the rectum wall volume should receive >78 Gy.
Bladder wall
(i) No more than 60% of the bladder wall volume should
receive >40 Gy, and (ii) no more than 35% of the bladder
wall volume should receive >70 Gy.
Large bowel
No more than 0.5 ml of the large bowel should receive
>65 Gy.
Small bowel
No more than 0.5 ml of the small bowel should receive
>60 Gy.
Orthogonal kV X-ray planar images and CBCT
data acquisition
Prior to irradiation, patients were first aligned based on
tattoos on the skin indicating the planning isocenter (IC) lo-
cation with a system of wall-mounted alignment lasers. A
pair of orthogonal kV X-ray planar images was then obtained
using the on-board imager systems of a Clinac iX (Varian
Medical Systems, Palo Alto, CA). These kV X-ray planar
images were manually aligned to their corresponding digital-
ly reconstructed radiographs by therapists and independently
verified by physicians. The manual alignment provided left–
right (LR), anterior–posterior (AP), and superior–inferior
(SI) couch shifts, which were applied to the treatment couch.
Respective couch shift values show the matching difference
between the laser and kV image.
After correcting initial set-up errors based on bony anatomy,
a CBCT scan was sequentially acquired on first, second and
third fractions, and thereafter on the first day of the week. The
maximum reconstructed field-of-view was a circle of 450 mm
diameter and 180 mm in length. For each patient, seven to 14
(average nine) CBCT datasets were acquired during the whole
treatment course of 7–8 weeks. When target positions were
deviated from the PTV, we confirmed the target position on
second CBCT images after the initial target matching.
The prostate, bladder wall and rectum wall were again
determined (in the same manner as described in ‘Planning
CT data acquisition and IMRT planning’) on the acquired
CBCT datasets. Center of mass (COM) mismatches for the
prostate between the planning CT and each CBCT dataset
were then calculated in the LR, AP and SI directions. In
the present study, rotational errors were not evaluated.
Subsequently, the systematic variation ∑ (standard deviation
of the average shifts for the patient cohort) and the random
variation σ (root-mean-square of the standard deviations of
the shifts for all patients) were calculated for the LR, AP and
SI directions.
Set-up corrections
To evaluate interfractional variations in dose–volume
metrics under different set-up error corrections, six set-up
error corrections were employed as follows.
SEtattoo
Patients were aligned only based on the tattoos.
SEbone
After aligning patients based on the tattoos, set-up error was
corrected on-line based on bony anatomy using orthogonal
kV X-ray planer images.
Table 2. Dose–volume constraints in IMRT planning
Structure Dose–volume constraints
PTV Maximum dose ≤110%
V90% > 96% (98%)
D95% > 90% (95%)
99% ≤Mean dose ≤103%
Rectum wall V40 Gy ≤ 60%
V60 Gy ≤ 30%
V70 Gy ≤ 20%
V78 Gy < 1%
Bladder wall V40 Gy ≤ 60%
V70 Gy ≤ 35%
Large bowel V65 Gy ≤ 0.5 ml
Small bowel V60 Gy ≤ 0.5 ml
Values in parentheses are preferable. PTV = Planning target
volume, V90% = volume receiving 90% of the prescription
dose, D95% = dose received by 95% volume, Vxx Gy = the
volume receiving more than xx Gy.
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SECOM1
Set-up error on second and later fractions was corrected
off-line based on the COM of the first CBCT acquisition
only.
SECOM2
Set-up error on the third and later fractions was corrected
off-line based on the averaged COM of the first two CBCT
acquisitions.
SECOM3
Set-up error on the fourth and later fractions was corrected
off-line based on the averaged COM of the first three CBCT
acquisitions.
SECOMall
Set-up error was corrected virtually on-line based on the
COM of every CBCT acquisition.
Dose recalculation on CBCT images under
the different set-up corrections above
After incorporating these set-up errors into planning the IC
position, dose distributions were recalculated on CBCT
images under the same conditions as in planning using the
electron density conversion table obtained from the planning
CT scanner. Although CBCT-based treatment plans are dosi-
metrically comparable with planning CT-based plans [12],
there are some differences in the electron density conversion
tables between planning CT and CBCT [13]. In the present
study, after comparing the IC dose on CBCT images with
that on the planning CT, the IC dose on CBCT images was
normalized to that on the planning CT plan based on the
results presented by Hatton et al. [10]. Accordingly, monitor
units were different from the planned ones.
Dose–volume metrics of the prostate, rectum wall and
bladder wall were calculated from the relevant histograms.
As for the rectum wall and bladder wall, V90% and V100%
(volumes receiving 90% and 100%, respectively, of the pre-
scription dose) were obtained, because higher doses have
more impact on the complication probability [14]. Results
for different set-up corrections were compared using analysis
of variance (ANOVA) with Dunnett tests, where P < 0.05
was considered statistically significant.
RESULTS
COM distance
The COM distances with the respective set-up error correc-
tions are shown in Fig. 2. Mean ± SD of set-up error in the
LR, AP and SI directions was 0.2 ± 3.1 mm, −0.1 ± 3.1 mm,
and 0.0 ± 3.1 mm, respectively, in the SEtattoo groups, versus
−0.2 ± 0.7 mm, −0.3 ± 2.4 mm, and 0.0 ± 0.4 mm, respect-
ively, in the SEbone groups, showing a significant difference
between these two groups (P < 0.05). Mean ± SD of set-up
errors for the SECOM groups (excluding the SECOM1 groups)
was comparable with that of the SEbone groups in all direc-
tions (Fig. 2).
∑ and σ were <1.0 mm in the LR and SI directions, re-
spectively, except in the SEtattoo groups. ∑ was < 2.0 mm in
the AP direction, except in the SECOM1 groups (2.4 mm), in
which σ was <2.0 mm. ∑ in the SECOM3 groups was compar-
able with that in the SEbone groups in the AP direction. The
frequency of >5.0 mm displacement in the AP direction was
10.7% in the SEtattoo, 10.4% in the SEbone, 6.2% in the
SECOM1, 5.6% in the SECOM2, and 4.0% in the SECOM3
groups. Meanwhile, the frequency of > 8.0 mm displacement
in the AP direction was 2.2% in the SEtattoo, 1.3% in the
SEbone, 0.5% in the SECOM1, 0.6% in the SECOM2, and 0.7%
in the SECOM3 groups.
Dosimetric evaluation
Figure 3 shows interfractional variation in prostate V100%
and D95% (the dose delivered to 95% of the prostate volume)
for the PTV8/5 and PTV5/5 groups. Averaged reductions in
prostate V100% and D95% were within 2.5% and 1.0%, except
for the SEtattoo groups. ANOVA showed a statistically signifi-
cant difference between the SEtattoo and SEbone groups
(P < 0.05); however, no significant difference was seen
between the SEbone and other SECOM groups.
Compared with the planned dose for the rectum wall and
bladder wall, V100% and V90% were delivered an excessive
dose (Figs 4 and 5). Significant differences in these dose–
volume metrics were seen between the SEtattoo and other
groups (P < 0.05).
Compared with the PTV8/5 margin groups, the SD of the
prostate V100% and D95% were increased, while the rectum
V100% and V90% and bladder V100% and V90% were decreased
for the PTV5/5 margin groups (Figs 4 and 5); however, there
were no significant differences in averaged dose–volume
metrics between the PTV8/5 margin and PTV5/5 margin groups.
DISCUSSION
Hammond et al. evaluated residual set-up errors using
CBCT images, and reported that the total mean ± SD for five
patients was 0.7 ± 0.6 mm, 1.6 ± 1.2 mm and 1.4 ± 1.0 mm
in the LR, AP and SI directions, respectively [7]. Compared
with the results of their study, residual set-up errors based on
bony anatomy were smaller in our study. One possible
reason for this difference is a decrease in statistical uncer-
tainty, given the small number of patients (n = 5) in their
study. Recently, many studies have reported on set-up error
corrections using implanted fiducial markers. Interestingly,
some of these reported the presence of prostate motion
against the bony anatomy [15–17]. McNair et al. reported
that systematic error (calculated using gold markers rather
than bony anatomy) was >2.0 mm different in at least one
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direction in 50% of patients (with a difference >5.0 mm in
13% of patients) using fiducial markers as opposed to bony
anatomy [17]. In the present study, fiducial markers were
not implanted for all participating patients, and the COM
mismatches were calculated based on the delineated prostate.
Nevertheless, our results for prostate displacement from the
bony anatomy were comparable with their results. Displacement
in the AP direction may be attributable to contraction of pelvic
muscles or a change in rectal volume [18, 19]. Of all set-up
error correction policies, the SECOM1 groups had the largest
∑ in the AP direction (2.4 mm), indicating that systematic
set-up error cannot be reduced by a single measurement only.
Prostate position in the first fraction is less representative; a
decrease in systematic set-up errors therefore requires mul-
tiple positional data for the prostate.
In order to reduce the risk of toxicity, it is important to set
valid dose–volume constraints. According to the report pub-
lished by Michalski et al., most dose–volume parameters sig-
nificantly associated with late rectal toxicity considered
doses ≥60 Gy [14]. Our dose–volume constraints to the
rectum wall (Table 2) satisfied their recommended dose–
volume limits [14]. However, it is generally known that inter-
fractional variations in doses to organs at risk (OARs) occur.
Kupelian et al. [5], Hatton et al. [10] and van Haaren et al.
[20] all reported that rectal doses were generally higher than
the planned dose. These results are consistent with those of
Fig. 2. COM distance in the (a) LR, (b) AP, and (c) SI direction. Dose analysis parameters are graphically presented in box plots (showing
medians, and 25th and 75th percentiles) with whiskers (10th and 90th percentiles); outliers are shown as dots. ‘ >n mm (%)’ means a
frequency of displacement of >nmm.
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our present study (Figs 4 and 5). Variations in the volume
and shape of OARs (and a different set-up from the planning)
cause interfractional variations in doses to OARs, which
would result in unintentional toxicities, even with well-
established dose–volume constraints; therefore, the prepar-
ation prior to treatment and the establishment of a matching
protocol are required to control the variations. Figures 4 and 5
revealed that set-up error correction based on target matching
was effective in minimizing the interfractional variations in
doses to OARs, while the tattoos-based set-up error correc-
tion caused the largest ones. These results indicated that it is
preferable to employ target matching when bowel gas and
stool are present.
Our results showed that the margin reduction plan allowed
sparing of the bladder and rectal high-dose regions as indi-
cated by Hammond et al. [7]. Our present retrospective
Fig. 3. Interfractional variation in prostate (a) V100% and (b) D95%. Data are shown in percentage points. In each set-up
correction policy, the left and right box plots show data in the PTV8/5 and PTV5/5 groups, respectively. Dose analysis
parameters are graphically presented in box plots (showing medians, and 25th and 75th percentiles) with whiskers (10th and
90th percentiles); outliers are shown as dots.
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analysis found that no significant differences in the prostate
V100% and D95% between the PTV8/5 margin and PTV5/5
margin groups were observed, even under bony set-up cor-
rection when employing our CTV determination policy and
immobilization system. Recently, Engels et al. have reported
a potential danger posed by image-guidance techniques with
regard to PTV margin reduction [21]; thus, the differences in
a treatment protocol, including CTV determinations, PTV
margin settings and immobilization systems, would influ-
ence treatment outcomes, even with full use of the image-
guidance function.
Three limitations of our study warrant mention. (i) CBCT
was not scanned at the time of delivery of every fraction.
Certainly, it is preferable to acquire CBCT data for accurate
evaluation because the shape of the OAR and prostate
changes daily; however, we decided not to do this with a
Fig. 4. Interfractional change in rectum wall (a) V100% and (b) V90%. For each set-up correction policy, the left and right
box plots show data in the PTV8/5 and PTV5/5 groups, respectively. Dose analysis parameters are graphically presented in
box plots (showing medians, and 25th and 75th percentiles) with whiskers (10th and 90th percentiles); outliers are shown as
dots.
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view to minimizing exposure [22]. From our results, the
number of CBCT data was sufficient to evaluate dosimetry.
(ii) Intrafractional prostate motion was not considered.
Several reports on the intrafractional motion have been pub-
lished to date [23–25]. The representative intrafractional
motions are respiratory motion and baseline drift of prostate
position. In general, respiratory motion of the prostate was
mostly less than our PTV margin size of 5 mm [23, 24];
therefore, respiratory motion would have little influence on
the dosimetry. However, baseline drift will cause unpredict-
able systematic errors [25], which cannot be quantified on
CBCT images. To address this issue, real-time monitoring is
required. (iii) Deformable image registration (DIR) methods
were not used. Song et al. previously reported that a change
in the volume and shape of organs had only a moderate influ-
ence on dosimetry for prostate cancer, even if DIR methods
Fig. 5. Interfractional change in bladder wall (a) V100% and (b) V90%. For each set-up correction policy, the left and right
box plots show data in the PTV8/5 and PTV5/5 groups, respectively. Dose analysis parameters are graphically presented in
box plots (showing medians, and 25th and 75th percentiles) with whiskers (10th and 90th percentiles); outliers are shown as
dots.
Evaluation of different set-up error corrections on dose–volume metrics in prostate IMRT using CBCT images 973
were used [26]; accordingly, we expected that no significant
difference would be seen in dosimetry between delivery with
and without DIR.
CONCLUSION
We retrospectively analyzed the dose delivered to the pros-
tate, rectal wall and bladder wall in a total of 270 CBCT sets
from 30 consecutive prostate cancer patients treated with
IMRT under the six different set-up error corrections and two
PTV margin settings. The dose distributions obtained with a
set-up correction based on tattoo only were significantly
worse than those yielded by the others. As expected, varia-
tions between the planned and delivered doses were smallest
when target matching was applied. However, the use of bony
set-up correction still ensured the delivery of planned doses
in IMRT for prostate cancer. In addition, doses to OARs
were reduced by shrinking the PTV margin size; however,
interfractional variations in dose–volume metrics were
almost fully consistent in the PTV8/5 and PTV5/5 groups,
even under different set-up error corrections.
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